1.87
Durect Corp stock is traded at $1.87, with a volume of 1.08M.
It is down -2.09% in the last 24 hours and up +194.40% over the past month.
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
See More
Previous Close:
$1.91
Open:
$1.88
24h Volume:
1.08M
Relative Volume:
1.18
Market Cap:
$58.05M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
-3.0656
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
+218.24%
1M Performance:
+194.40%
6M Performance:
+144.44%
1Y Performance:
+14.72%
Durect Corp Stock (DRRX) Company Profile
Name
Durect Corp
Sector
Phone
(408) 777-1417
Address
10240 BUBB ROAD, CUPERTINO, CA
Compare DRRX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DRRX
Durect Corp
|
1.87 | 59.29M | 8.59M | -17.07M | -21.90M | -0.61 |
![]()
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-30-20 | Initiated | Chardan Capital Markets | Buy |
Oct-12-20 | Initiated | ROTH Capital | Buy |
Jul-31-20 | Initiated | Oppenheimer | Outperform |
Jan-31-20 | Initiated | B. Riley FBR | Buy |
Nov-18-19 | Resumed | Cantor Fitzgerald | Overweight |
Sep-06-19 | Initiated | Cantor Fitzgerald | Overweight |
Mar-06-18 | Upgrade | H.C. Wainwright | Neutral → Buy |
Oct-20-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
Oct-20-17 | Reiterated | Laidlaw | Buy |
Oct-20-17 | Downgrade | Stifel | Buy → Hold |
Jul-12-17 | Upgrade | Stifel | Hold → Buy |
Feb-28-17 | Resumed | H.C. Wainwright | Buy |
Apr-25-16 | Initiated | Rodman & Renshaw | Buy |
May-01-15 | Reiterated | Cantor Fitzgerald | Buy |
May-01-15 | Reiterated | Stifel | Buy |
Mar-25-13 | Initiated | Stifel | Buy |
Nov-01-12 | Downgrade | C.K. Cooper | Buy → Hold |
Aug-17-12 | Initiated | C.K. Cooper | Buy |
Jun-23-09 | Initiated | Caris & Company | Buy |
Mar-26-09 | Initiated | Wedbush Morgan | Hold |
View All
Durect Corp Stock (DRRX) Latest News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - The Malaysian Reserve
Does DURECT Corporation show high probability of reboundEarly Entry Planner for Swing Candidates - Newser
Bausch Health files SC TO-C ahead of tender offer for DURECT (DRRX) | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health expands liver disease portfolio with DURECT Corp buy - The Pharma Letter
Can swing trading help recover from DURECT Corporation lossesSwing Watchlist With Tight Stop Placement - Newser
What does recent volatility data suggest for DURECT CorporationLow Risk High Confidence Watchlist Builder - Newser
Durect Corp: Analyzing DRRX Stock Trends - investchronicle.com
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside - FinancialContent
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - inkl
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views - Benzinga
Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell data - Endpoints News
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings - Benzinga
Bausch Health stock rises, Durect flies after acquisition deal By Investing.com - Investing.com Canada
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders - Business Wire
Durect stock rises on M&A deal with Bausch Health (BHC:NYSE) - Seeking Alpha
DRRX to be acquired by Bausch for $1.75 cash + CVR worth up to $350M | DRRX SEC FilingForm 8-K - Stock Titan
Bausch Health To Acquire DURECT; Expanding Liver Disease Pipeline With Larsucosterol - Nasdaq
Bausch Health to acquire DURECT in $63 million deal for liver disease drug - Investing.com Canada
Bausch Health to acquire DURECT for $63 million upfront By Investing.com - Investing.com Canada
Bausch Health to launch tender offer for DURECT; Schedule TO-C filed | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire
Can volume confirm reversal in DURECT CorporationForecasting Stock Moves with AI Insights - Newser
When is the best time to exit AA Mission Acquisition Corp.Free Community Shared Smart Money Signals - Newser
Is ICF International Inc. stock overhyped or has real potentialFree Low Risk Buy Zone Opportunity Watch - Newser
How Aeries Technology Inc Equity Warrant stock performs during market volatilityFree Accurate Technical Trend Reversal Picks - Newser
Short Term Trend Reversal in DURECT Corporation PossibleLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
How to forecast Kornit Digital Ltd. trends using time seriesBreakout Monitoring with Momentum Analysis - Newser
Is it the right time to buy DURECT Corporation stockIdentify breakout stocks before they peak - jammulinksnews.com
How Interest Rate Changes Impact CCSI Stock PerformanceLow Risk ROI Maximization - Newser
What makes Atlantic Union Bankshares Corporation stock price move sharplyFree VIP Investment Strategies - Newser
Moving Average Trends for DURECT Corporation Stock: What They IndicateWealth Building Stock Portfolio - Newser
What makes BBUC stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Why DURECT Corporation stock attracts strong analyst attentionFree Exclusive Group - Newser
Why Visionary Holdings Inc. stock attracts strong analyst attentionLow Risk Scalping Alerts - Newser
What makes Bio Techne Corporation stock price move sharplyTop Rated Trade Entries - Newser
Is DURECT Corporation a good long term investmentUnmatched market performance - PrintWeekIndia
What analysts say about DURECT Corporation stockSuperior capital gains - PrintWeekIndia
What analysts say about Bowen Acquisition Corp stockLightning-fast capital gains - PrintWeekIndia
Does Veren Inc. stock pay reliable dividendsConsistently exceptional gains - jammulinksnews.com
Indus Towers Limited (INDUSTOWER) vs yyyLightning-fast capital gains - jammulinksnews.com
Would You Accumulate or Wait on Fabtech Technologies Cleanrooms Limited (544332)Lightning-fast capital gains - jammulinksnews.com
DURECT Corporation Stock Analysis and ForecastFree Bull & Bear Market Updates - Autocar Professional
Is GOLD a good long term investmentSuperior stock selection - jammulinksnews.com
What drives Sizzle Acquisition Corp. II Debt Equity Composite Units stock priceFree Stock Market Trend Analysis - jammulinksnews.com
Best Indian Stocks for Tax Savings Smart Investment TechniquesGame-changing capital returns - jammulinksnews.com
Best Banks to Invest in India High Growth Investment OptionsPhenomenal capital appreciation - jammulinksnews.com
Best Banking Stocks to Buy Expert Investment InsightsPhenomenal wealth increase - Autocar Professional
What analysts say about DRDB stockConsistent triple-digit returns - Autocar Professional
Best Technology Stocks in India Short Term Profit StocksFastest return on investment - Autocar Professional
QuickLogic Corporation Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
Is Investcorp AI Acquisition Corp. Equity Warrant a good long term investmentAccelerated capital growth - PrintWeekIndia
Durect Corp Stock (DRRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):